BIOMAT Database Logo BIOMAT Database Logo

[A case of CEA and CA19-9 producing recurrent transitional cell carcinoma in an Indiana pouch after total cystectomy]. 1996

Y Miyoshi, and T Asakura, and J Matsuzaki, and M Fukuda, and Y Satomi, and H Akabane
Department of Urology, Yokosuka Kyosai Hospital.

A 73-year-old female with transitional cell carcinoma (TCC) of the bladder underwent total cystectomy and Indiana pouch replacement in April, 1992. Histological examination revealed grade 3 TCC. In February 1995, she complained of gross hematuria. Intravenous pyelography (IVP) revealed a right non-functional kidney and filling defect in the Indiana pouch. We suspected colon cancer in the Indiana pouch because the levels of serum carcino-embryonic antigen (CEA) and CA19-9 were elevated. Endoscopic biopsy of intrapouch tumor was done. Pathological examination revealed grade 2 TCC. In July 1995, right nephroureterectomy with resection of Indiana pouch was performed and the surgical specimen revealed renal pelvic and ureteral cancer, grade 2 TCC. The levels of serum CEA and CA19-9 returned to the normal range 21 days after the operation. CEA and CA19-9 histochemical stain of renal pelvic and ureteral cancer were positive. Also CEA-, CA19-9-positive cells were detected in the specimens of the bladder tumor from the total cystectomy performed in 1992. This rare case is discussed and the literature is reviewed.

UI MeSH Term Description Entries
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D015653 Cystectomy Surgical removal of the full or partial removal of the URINARY BLADDER. Partial Cystectomy,Radical Cystectomy,Cystectomies,Cystectomy, Partial,Cystectomy, Radical,Partial Cystectomies,Radical Cystectomies

Related Publications

Y Miyoshi, and T Asakura, and J Matsuzaki, and M Fukuda, and Y Satomi, and H Akabane
Adenocarcinoma in an indiana pouch after cystectomy for transitional cell carcinoma.
March 2001, The Journal of urology,
Y Miyoshi, and T Asakura, and J Matsuzaki, and M Fukuda, and Y Satomi, and H Akabane
[A case of transitional cell carcinoma of the renal pelvis with adenocarcinoma producing CEA and CA19-9].
September 2004, Hinyokika kiyo. Acta urologica Japonica,
Y Miyoshi, and T Asakura, and J Matsuzaki, and M Fukuda, and Y Satomi, and H Akabane
[A case of CA19-9 producing transitional cell carcinoma of the ureter].
September 2003, Hinyokika kiyo. Acta urologica Japonica,
Y Miyoshi, and T Asakura, and J Matsuzaki, and M Fukuda, and Y Satomi, and H Akabane
CA19-9-producing transitional cell carcinoma of the renal pelvis: a case report.
March 2001, Hinyokika kiyo. Acta urologica Japonica,
Y Miyoshi, and T Asakura, and J Matsuzaki, and M Fukuda, and Y Satomi, and H Akabane
[A case of transitional cell carcinoma of renal pelvis with extremely high serum levels of CA19-9 and CEA].
July 1997, Hinyokika kiyo. Acta urologica Japonica,
Y Miyoshi, and T Asakura, and J Matsuzaki, and M Fukuda, and Y Satomi, and H Akabane
[A case of transitional cell carcinoma of the urinary bladder with high serum level of CEA and CA19-9].
August 2001, Hinyokika kiyo. Acta urologica Japonica,
Y Miyoshi, and T Asakura, and J Matsuzaki, and M Fukuda, and Y Satomi, and H Akabane
[Gallbladder carcinoma producing CEA, AFP, CA19-9, sialyl SSEA and CSF].
January 1996, Ryoikibetsu shokogun shirizu,
Y Miyoshi, and T Asakura, and J Matsuzaki, and M Fukuda, and Y Satomi, and H Akabane
[A case of CA19-9 producing transitional cell carcinoma of the ureter effectively responsive to combination chemotherapy].
November 1992, Hinyokika kiyo. Acta urologica Japonica,
Y Miyoshi, and T Asakura, and J Matsuzaki, and M Fukuda, and Y Satomi, and H Akabane
[Bronchioloalveolar carcinoma producing CA19-9].
June 2011, Kyobu geka. The Japanese journal of thoracic surgery,
Y Miyoshi, and T Asakura, and J Matsuzaki, and M Fukuda, and Y Satomi, and H Akabane
[Bilateral upper tract urothelial carcinoma eight years after total cystectomy and Indiana pouch urinary diversion for bladder cancer : a case report].
September 2011, Hinyokika kiyo. Acta urologica Japonica,
Copied contents to your clipboard!